ST/HR slope during prostacyclin treatment: an improved method to identify patients with advanced coronary artery

R Bugiardini1, A Borghi, G Morgagni

  • 1Institute of Patologia Medica, University of Bologna, Italy.

European Heart Journal
|November 1, 1989
PubMed

Insights

Iloprost improved the accuracy of the ST/HR slope test in diagnosing coronary artery disease severity. This prostacyclin analogue enhanced coronary flow reserve, particularly in patients with less severe atherosclerosis.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacology

Background:

  • Exercise-induced coronary artery constriction can reduce coronary flow reserve.
  • This constriction may limit the accuracy of the ST/HR slope in assessing coronary artery disease severity.

Purpose of the Study:

  • To evaluate the effect of iloprost-induced coronary vasodilation on the diagnostic accuracy of the ST/HR slope.
  • To compare ST/HR slopes during placebo versus iloprost administration in patients with coronary artery disease.

Main Methods:

  • 42 patients with angina and coronary artery disease underwent exercise testing with ST/HR slope analysis.
  • Tests were performed with placebo and during infusion of iloprost (a prostacyclin analogue).
  • A subset of patients (n=7) underwent repeat testing during right heart catheterization.

Main Results:

  • Iloprost improved the overall diagnostic accuracy of the ST/HR slope compared to placebo, especially in advanced coronary artery disease.
  • A rightward shift in the ST/HR slope was observed with iloprost in one- and two-vessel disease, but not in three-vessel or left main stem disease.
  • Higher coronary blood flow during iloprost infusion suggests prevention of dynamic coronary events, potentially benefiting patients with minor atherosclerosis.

Conclusions:

  • Iloprost enhances the diagnostic utility of the ST/HR slope for coronary artery disease severity.
  • The drug's benefits appear more pronounced in patients with less advanced atherosclerotic disease.
  • Iloprost may mitigate exercise-induced reductions in coronary flow reserve through prevention of dynamic coronary events.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...